Skip to content

Pharma Collin

Active Private limited companyfounded 2024active for 2 yearsDoornlaarstraat 40, 2820 BonheidenKBO/BCE: BE 1009.523.540

Lifetime

1 annual account with figures
peak of €9,000 in 2025
€9,000 
peak of €1,305 in 2025
€1,305 
peak of €6,305 in 2025
€6,305 
€267,413 
Board1 name since 2024
1 director
Documentsfilings and deeds
27-11-202527 days late
2025abbreviated format
First year with figures

Key points

from the 2025 annual accounts

Debts

€267,413 98% of the balance sheet
Financial debts 91%Suppliers 0%Taxes and wages 2%Other 7%

€155,910 of the debts are secured on the company's own assets.

Subsidiaries

-€11,682

Subsidiary with negative equity. · loss of €7,046 in 2024.

Position in the sector

€6,305

Less equity than 87% of companies in office administrative support. Sector median €305,019 · 2,843 companies.

2025 accounts filed 27 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,136 companies had the same profile as Pharma Collin has now. Each dot stands for 6 companies, two years later.

92.1%
were still trading
2.3%
stopped another way
5.2%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit under 5% of the balance sheet

Another 0.4% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,136 companies, not a prediction for Pharma Collin. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 21-05-2024
  • 100 sharesdeed of 23-05-2024

Shares in 1 company,

Board & ownership

Recent changes

Incorporation Founding capital of €5,000, 100 shares · Founder: · Appointment: (director) · published on 23-05-2024 · Gazette deed
First establishment Doornlaarstraat 40, Bonheiden
All 3 events

Comparable companies

same main activity, similar in size and age
Company
Pharma Collin Bonheiden €273,718 €9,000 2.3% -
LEGEND FLEET EU Antwerp €361,864 €7,023 2.9% -
ULM TECHNICS Péruwelz €331,109 €11,813 -2.7% -
Andy DC Buggenhout €262,957 €10,410 3.3% -
ONE STEP AHEAD Sint-Gillis (bij-Brussel) €305,947 €11,548 6.5% -
EDR Project Solutions Sint-Truiden €231,674 €14,024 6.6% -
Entourage GP Ghent €311,859 €13,547 35.9% 0.6

These companies have the same main activity as Pharma Collin: other business support services (NACE 82990). They are comparable in size and age: total assets between €232,000 and €362,000, founded between 2023 and 2025.

Official details

Source: KBO
Status
Active since 21-05-2024Normal situation
Activity
Other business support servicesNACE 82990
Establishment unit
2.360.097.7932820 Bonheiden, since 21-05-2024
Financial year end
31 March
Peppol
Not found in the Peppol Directory
Company details

Annual accounts to 31-03-2025

≈ €52,000estimated
€273,718
Filing
Filed on 27-11-2025
Financials

Insights on Pharma Collin

Pharma Collin has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €6,305 and a net result of €1,305.

Its solvency ranks better than 13% of 2,842 sector peers (NACE 82) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Pharma Collin

What is the company number of Pharma Collin?
The company number of Pharma Collin is 1009.523.540. The VAT number is the same number with BE in front: BE 1009.523.540.
Where is Pharma Collin based?
The registered office is at Doornlaarstraat 40, 2820 Bonheiden.Company details
What does Pharma Collin do?
According to the KBO register, the main activity is other business support services (NACE 82990).
What is the legal form of Pharma Collin?
Pharma Collin is a private limited company (BV).
When was Pharma Collin founded?
Pharma Collin was founded on 21-05-2024.
Is Pharma Collin still active?
Yes, Pharma Collin is an active enterprise in the KBO register.
What is the turnover of Pharma Collin?
The turnover in financial year 2025 is ≈ €52,000. This figure is estimated from the gross margin of €9,000 and 69 comparable companies (NACE 82990). It probably lies between €25,000 and €110,000. It is a rough estimate.Financials
Is Pharma Collin profitable?
In financial year 2025, Pharma Collin made a profit of €1,305.
Where can I find the annual accounts of Pharma Collin?
Pharma Collin filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.